Literature DB >> 22348822

Identification Keratin 1 as a cDDP-resistant protein in nasopharyngeal carcinoma cell lines.

Sanyuan Tang1, Weiguo Huang, Meizuo Zhong, Leilan Yin, Hao Jiang, Suping Hou, Pingping Gan, Yujuan Yuan.   

Abstract

Multidrug resistance (MDR) to anticancer drugs is a major obstacle to successful chemotherapy of tumors. Understanding the molecular basis to chemoresistance is likely to provide better treatment. Cell lines resistant to cis-diamminedichloroplatinum (CNE2/cDDP) were established from human nasopharyngeal carcinoma (NPC) cell lines CNE2. Comparative proteomics involving 2-dimensional gel electrophoresis (2-DE) and ESI-Q-TOF-MS were performed on protein extracted from CNE2 and CNE2/cDDP cell lines to screen drug resistance-related proteins. Keratin 1 (KRT1), cathepsin D (CTSD) and annexin a5 (ANXA5) were identified as three proteins showing higher expression in CNE2/cDDP compared to CNE2. Furthermore, suppression of KRT1 expression by siRNA resulted in decreased MDR in siRNA-CNE2/cDDP cells. And upregulation of KRT1 could result in increased of drug resistance in NPC cell lines. Taken together, KRT1 protein and its activity levels were higher in cDDP-resistant NPC cell lines compared to their parental cell lines. These data clearly linked KRT1 and cDDP resistance mechanisms. KRT1 could serve as a biomarker for chemotherapy sensitivity of NPC. Crown
Copyright © 2012. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22348822     DOI: 10.1016/j.jprot.2012.02.003

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  10 in total

1.  iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma.

Authors:  Kun Wang; Zhen Chen; Lu Long; Ya Tao; Qiong Wu; Manlin Xiang; Yunlai Liang; Xulin Xie; Yuan Jiang; Zhiqiang Xiao; Yahui Yan; Shiyang Qiu; Bin Yi
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

Review 2.  Keratin 1 as a cell-surface receptor in cancer.

Authors:  Oluseye Ogunnigbagbe; Christopher G Bunick; Kamaljit Kaur
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-12-07       Impact factor: 11.414

3.  Identification of differentially expressed proteins in chemotherapy-sensitive and chemotherapy-resistant diffuse large B cell lymphoma by proteomic methods.

Authors:  Yiping Liu; Liang Zeng; Shusheng Zhang; Shan Zeng; Jin Huang; Youhong Tang; Meizuo Zhong
Journal:  Med Oncol       Date:  2013-03-16       Impact factor: 3.064

Review 4.  A Review: Proteomics in Nasopharyngeal Carcinoma.

Authors:  Ze-Tan Chen; Zhong-Guo Liang; Xiao-Dong Zhu
Journal:  Int J Mol Sci       Date:  2015-07-08       Impact factor: 5.923

5.  Proteomic Differences in Feline Fibrosarcomas Grown Using Doxorubicin-Sensitive and -Resistant Cell Lines in the Chick Embryo Model.

Authors:  Katarzyna Zabielska-Koczywąs; Katarzyna Michalak; Anna Wojtalewicz; Mateusz Winiarczyk; Łukasz Adaszek; Stanisław Winiarczyk; Roman Lechowski
Journal:  Int J Mol Sci       Date:  2018-02-14       Impact factor: 5.923

6.  Overexpression of annexin A5 might guide the gemtuzumab ozogamicin treatment choice in patients with pediatric acute myeloid leukemia.

Authors:  Nan Zhang; Ying Zhang; Ping Zhang; Shifeng Lou; Ying Chen; Huan Li; Hanqing Zeng; Yan Shen; Jianchuan Deng
Journal:  Ther Adv Med Oncol       Date:  2020-05-27       Impact factor: 8.168

7.  Serum and tissue proteomic signatures of patients with hepatocellular carcinoma using 2‑D gel electrophoresis.

Authors:  Huifang Peng; Zhijian Yan; Xinhua Zeng; Sheng Zhang; Hongwei Jiang; Heqing Huang; Huiqin Zhuo
Journal:  Mol Med Rep       Date:  2019-05-29       Impact factor: 2.952

8.  Early diagnosis of colorectal cancer via plasma proteomic analysis of CRC and advanced adenomatous polyp.

Authors:  Setareh Fayazfar; Hakimeh Zali; Afsaneh Arefi Oskouie; Hamid Asadzadeh Aghdaei; Mostafa Rezaei Tavirani; Ehsan Nazemalhosseini Mojarad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

Review 9.  Pathobiological functions and clinical implications of annexin dysregulation in human cancers.

Authors:  Llara Prieto-Fernández; Sofía T Menéndez; María Otero-Rosales; Irene Montoro-Jiménez; Francisco Hermida-Prado; Juana M García-Pedrero; Saúl Álvarez-Teijeiro
Journal:  Front Cell Dev Biol       Date:  2022-09-28

10.  Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells.

Authors:  Lei Wu; Liang Yang; Yu Xiong; Hua Guo; Xiaoli Shen; Zujue Cheng; Yan Zhang; Ziyun Gao; Xingen Zhu
Journal:  Tumour Biol       Date:  2014-09-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.